PULMATRIX, INC. Prepaid Expense and Other Assets
PULMATRIX, INC. (PULM) had Prepaid Expense and Other Assets of $289.00 thousand as of 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Balance Sheet › Assets
us-gaap:PrepaidExpenseAndOtherAssets · last filed 2014-11-13
- 2014-09-30: Prepaid Expense and Other Assets $289.00K.
- 2014-06-30: Prepaid Expense and Other Assets $377.00K.
- 2014-03-31: Prepaid Expense and Other Assets $3.00K.
| Period end | Prepaid Expense and Other Assets |
|---|---|
| 2014-09-30 | $289.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $377.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $3.00K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |